<verdict>MOSTLY REALISTIC</verdict>
<score>8</score>
<reasoning>
The action and threat rolls are applied correctly throughout:
- **Action 1:** 41 against a 35% failure chance gives a narrow success.
- **Action 2:** 42 against 50% gives a mostly-failure.
- **Threats 1–3** materialise (17, 38 and 00 all fall below their thresholds).
- **Threats 4–5** do not (71 and 64 are above).

Materialised threats get proportionate effects and do not dominate the month:
- The per-stratum split and the Sep 15 rescore plan are a believable board compromise.
- The SecureBio slip to Aug 14 is a realistic delay for commissioned labelling.
- AISI observing rather than co-signing fits its institutional role.
- The ABA's vendor-neutrality refusal fits its role.

Pacing is mostly believable. A House hearing noticed seven days ahead is normal. Anthropic being limited to written testimony, with no bill following, fits R1. Hawley introducing the bill two weeks after the briefing is plausible because that push was already underway in June.

Actor reactions are well covered: xAI, Cato, CAISI-adjacent commentators, STAT, the campuses, the Michigan opposition and the federation all respond.

The main softness is that exogenous events lean mildly favourable. OpenAI filing its first v1 submission is plausible but convenient, and it is credited as a market driver. Trust scores also stay flat despite three new negative narratives. There is also a small internal tension: the science action "succeeds," yet CARB-X's maximum response time worsens from 31 to 40 hours despite the added staffing.
</reasoning>
<issues>
- OpenAI's first v1 submission is a helpful exogenous event, and the simulator gives no clear trigger for why it happens this month. It then contributes to the +1% market move.
- Public trust in Anthropic is unchanged at 26, even though three new negatives land: the Hawley "Anthropic data"/cartel framing, STAT's "Most nursing questions still blocked" follow-up, and "guards its own weights." A small decline would be more calibrated.
- CARB-X's maximum response worsens to 40 hours under a successful action that explicitly added staffing. This needs an explanation or should be reconciled.
- Threat 3's combined probability rose above the adversary's figure, but it resolved at 00, so both components fire regardless. There is no practical harm, but the logic for combining components should be stated consistently.
- CHS cumulative usage roughly doubles in one month (212 to 388 hours, 1,480 to 2,910 queries) with no stated reason, such as the renewal window or the new tools.
</issues>
<feedback_for_simulator>
- Give each exogenous event affecting other labs a concrete driver (a release schedule, regulatory pressure, a competitive move), and check that the month's exogenous mix is not tilting toward the player.
- Let accumulated negative narratives move trust scores modestly; do not hold them flat by default.
- Keep outcomes consistent with success rolls. If a successful action still shows a worse metric, name the cause.
- Next month, track the Hawley–Blumenthal bill realistically through August recess, meaning no movement. Also model whether the SecureBio Aug 14 date holds, rather than assuming it.
</feedback_for_simulator>
